Asterias Biotherapeutics (NYSE: AST) announced that the third patient was successfully dosed at Chicago-based Rush University Medical Center in a ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE